In an exclusive interview with Mr. Ankush Kapoor, Founder and CEO, and Mr. Sachin Joshi, Managing Director & Founder of PharmNXT Biotech, we explore the company's remarkable journey in revolutionizing biopharma. PharmNXT is making significant strides in both bioprocessing technologies and localized manufacturing, creating cutting-edge solutions for the growing demand for advanced therapies such as mRNA vaccines, cell and gene therapies, and antibody-drug conjugates. As the biopharma industry faces increasing challenges in cost, quality, and regulatory compliance, PharmNXT remains committed to ensuring affordable, high-quality solutions. In this conversation, the leaders share their vision for the future of biopharma, their approach to tackling emerging industry needs, and how they plan to expand PharmNXT’s global reach while maintaining a strong local manufacturing base.
As the biopharma industry continues to experience rapid innovation, the focus on manufacturing efficiency and affordability has never been more crucial. In this edition, we explore the evolution of biopharma manufacturing, with an emphasis on how localized production and cutting-edge technologies are shaping the future of the industry. As we dive into the complexities of scaling production while maintaining high-quality standards, this feature offers an inside look at how companies are overcoming the challenges of cost, regulatory compliance, and global supply chains. With advancements in personalized medicine, cell and gene therapies, and mRNA-based treatments, the role of biopharma manufacturers in driving these innovations forward is more important than ever.
© 2019 KIVAA Group | All right reserved. www.theindustrial.in
